Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 4, 2011, Pages 398-405

  Juul Hansen, Paul ^a   Rydning, Andreas ^b  

^a Rasta Medical Centre   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

esophagitis; Gastro esophageal reflux; heartburn; lansoprazole; proton pump inhibitors

Indexed keywords

CHROMOGRANIN A; GASTRIN; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG USE; DRUG WITHDRAWAL; ENDOSCOPY NEGATIVE REFLUX DISEASE; ESOPHAGEAL PH MONITORING; ESOPHAGITIS; FEMALE; GASTRIN BLOOD LEVEL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROSCOPY; HEARTBURN; HELICOBACTER PYLORI; HUMAN; MALE; OPEN STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; PROTEIN BLOOD LEVEL; REBOUND; SCORING SYSTEM; SIDE EFFECT; STOMACH ACID SECRETION; TREATMENT DURATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-ULCER AGENTS; CHROMOGRANINS; ESOPHAGITIS; FEMALE; GASTRIC ACID; GASTRINS; HEARTBURN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; REGURGITATION, GASTRIC; SECRETORY RATE;

EID: 79952585263     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.537684     Document Type: Article

References (19)

1. Hetzel DJ, Dent J, Reed WD, Narielvala FM,Mackinnon M, McCarthy JH, et al.. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
2. 2- receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output. Scand J Gastroenterol 1990;25:1144-50.
3. 2 receptor blockade. Gut 1991;32:1455-60.
4. El Omar E, Banerjee S, Wirz A, Penman I, Ardill JE, McColl KE: Marked rebound acid hypersecretion after treatment with ranitidine. Am J Gastroenterol 1996;91: 355-9.
5. Smith AD, Gillen D, Cochran KM, El Omar E, McColl KE. Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers. Am J Gastroenterol 1999;94: 1209-13.
6. Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996;39:649-53.
7. Gillen D, Wirz AA, Ardill JE, McColl KE. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999;116:239-47.
8. Lamberts R, Creutzfeldt W, Stockmann F, Jacubaschke U, Maas S, Brunner G. Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion 1988;39:126-35.
9. Klinkenberg-Knol EC, Festen HP, Jansen JB, Lamers CB,Nelis F, Snel P, et al.. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;121:161-7.
10. Sandvik AK, Brenna E, Waldum HL. Review pages: the pharmacological inhibition of gastric acid secretion- tolerance and rebound. Aliment Pharmacol Ther 1997;11: 1013-18.
11. Gillen D, Wirz AA, McColl KE. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment. Gastroenterology 2004;126: 980-8.
12. Hunfeld NG, Geus WP, Kuipers EJ. Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors. Aliment Pharmacol Ther 2007;25:39-46.
13. Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009;137:80-7, 87.
14. Niklasson A, Lindström L, Simrén M, Lindberg G, Björnsson E. Dyspeptic symptoms development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol 2010;105: 1531-7.
15. Juul-Hansen P, Rydning A. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice? Scand J Gastroenterol 2003;38: 1200-3.
16. el Omar EM, Banerjee S, Wirz A, McColl KE. The Glasgow Dyspepsia Severity Score-a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol 1996;8:967-71.
17. Fossmark R, Johnsen G, Johanessen E, Waldum HL. Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther 2005;21: 149-54.
18. Juul-Hansen P, Rydning A. On-demand PPI requirements in patients with endoscopy-negative GERD. J Clin Gastroenterol 2004;38:746-9.
19. Waldum HL, Qvigstad G, Fossmark R, Kleveland PM, Sandvik AK: Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scand J Gastroenterol. 2010;45:389-94. Review.